Reduction in Mortality and Teratogenicity Following Simultaneous Administration of Folic Acid and Vitamin E with Antiepileptic, Antihypertensive and Anti-allergic Drugs

Overview

Journal J Pharm Bioallied Sci

Specialty Pharmacology

Date 2014 Jul 19

PMID 25035638

Citations 2

Authors

Shahana Wahid

Rafeeq Alam Khan

Zeeshan Feroz

Affiliations

Soon will be listed here.

Abstract

Aim: The present study was designed to evaluate the teratogenic effects on breeding pattern in mice following administration of lamotrigine (LT) and levetiracetam (LV) and its combination with anti-hypertensive and anti-allergic drugs. Moreover, possibility of decrease in teratogenic effect was also evaluated upon simultaneous administration of these combinations with folic acid or vitamin E.

Materials And Methods: The study was carried out on mature female mice housed in polycarbonate breeding cages. Drugs were administered continuously till the birth of neonates and pups were examined for any teratogenic potential of drugs.

Results: The results of the study reveals that teratogenic effects of lamotrigine, methyldopa and loratadine (LTMLO) combination were seems to be reduced upon simultaneous administration with folic acid, while addition of vitamin E was found to be more effective in reducing the mortality rate of levetiracetam, methyldopa and loratadine combination.

Conclusion: Teratogenic effects of LTMLO combination were better prevented by folic acid. However, further studies on large number of animals and humans are required before reaching to definite conclusion.

Citing Articles

Molecular Mechanisms Underlying the Therapeutic Role of Vitamin E in Age-Related Macular Degeneration.

Edwards G, Olson C, Euritt C, Koulen P Front Neurosci. 2022; 16:890021.

PMID: 35600628 PMC: 9114494. DOI: 10.3389/fnins.2022.890021.

Effect of a short-term vitamin E supplementation on oxidative stress in infertile PCOS women under ovulation induction: a retrospective cohort study.

Chen J, Guo Q, Pei Y, Ren Q, Chi L, Hu R BMC Womens Health. 2020; 20(1):69.

PMID: 32252736 PMC: 7137506. DOI: 10.1186/s12905-020-00930-w.

References

Menon S . Psychotropic medication during pregnancy and lactation. Arch Gynecol Obstet. 2007; 277(1):1-13. DOI: 10.1007/s00404-007-0433-2. View

Boskovic R, Gargaun L, Oren D, Djulus J, Koren G . Pregnancy outcome following high doses of Vitamin E supplementation. Reprod Toxicol. 2005; 20(1):85-8. DOI: 10.1016/j.reprotox.2005.01.003. View

Finnell R . Teratology: general considerations and principles. J Allergy Clin Immunol. 1999; 103(2 Pt 2):S337-42. DOI: 10.1016/s0091-6749(99)70259-9. View

Morrell M . Epilepsy in women. Am Fam Physician. 2002; 66(8):1489-94. View

Aziz H, Ali S, Frances P, Khan M, Hasan K . Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia. 1994; 35(5):950-8. DOI: 10.1111/j.1528-1157.1994.tb02539.x. View

Dooley J, Camfield P, Gordon K, Camfield C, Wirrell Z, Smith E . Lamotrigine-induced rash in children. Neurology. 1996; 46(1):240-2. DOI: 10.1212/wnl.46.1.240. View

Luef G . Female issues in epilepsy: a critical review. Epilepsy Behav. 2009; 15(1):78-82. DOI: 10.1016/j.yebeh.2009.02.023. View

Danielsson I, Lister L . A pilot study of the teratogenicity of vagus nerve stimulation in a rabbit model. Brain Stimul. 2010; 2(1):41-9. DOI: 10.1016/j.brs.2008.06.008. View

Detrait E, George T, Etchevers H, Gilbert J, Vekemans M, Speer M . Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol. 2005; 27(3):515-24. PMC: 2727639. DOI: 10.1016/j.ntt.2004.12.007. View

10.

Arpino C, Brescianini S, Robert E, Castilla E, Cocchi G, Cornel M . Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia. 2000; 41(11):1436-43. DOI: 10.1111/j.1528-1157.2000.tb00119.x. View

11.

Bruno M, Harden C . Epilepsy in Pregnant Women. Curr Treat Options Neurol. 2001; 4(1):31-40. DOI: 10.1007/s11940-002-0003-7. View

12.

Lindhout D . Pharmacogenetics and drug interactions: role in antiepileptic-drug-induced teratogenesis. Neurology. 1992; 42(4 Suppl 5):43-7. View

13.

Min J, Park H, Park B, Kim Y, Park J, Lee H . Paraoxonase gene polymorphism and vitamin levels during pregnancy: Relationship with maternal oxidative stress and neonatal birthweights. Reprod Toxicol. 2006; 22(3):418-24. DOI: 10.1016/j.reprotox.2006.01.003. View

14.

Liebler D . The role of metabolism in the antioxidant function of vitamin E. Crit Rev Toxicol. 1993; 23(2):147-69. DOI: 10.3109/10408449309117115. View

15.

Chen C, Wells P . Enhanced tumorigenesis in p53 knockout mice exposed in utero to high-dose vitamin E. Carcinogenesis. 2006; 27(7):1358-68. DOI: 10.1093/carcin/bgi325. View

16.

van Gelder M, van Rooij I, Miller R, Zielhuis G, de Jong-van den Berg L, Roeleveld N . Teratogenic mechanisms of medical drugs. Hum Reprod Update. 2010; 16(4):378-94. DOI: 10.1093/humupd/dmp052. View

17.

Finnell R, Dansky L . Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: Animal studies. Reprod Toxicol. 1991; 5(4):281-99. DOI: 10.1016/0890-6238(91)90090-3. View

18.

Jacqz-Aigrain E, Koren G . Effects of drugs on the fetus. Semin Fetal Neonatal Med. 2005; 10(2):139-47. DOI: 10.1016/j.siny.2004.09.015. View

19.

Dolk H, Jentink J, Loane M, Morris J, de Jong-van den Berg L . Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?. Neurology. 2008; 71(10):714-22. DOI: 10.1212/01.wnl.0000316194.98475.d8. View

20.

Tettenborn B . Management of epilepsy in women of childbearing age: practical recommendations. CNS Drugs. 2006; 20(5):373-87. DOI: 10.2165/00023210-200620050-00003. View